Kaitlyn D’Onofrio

DocwireNews

<p>The Research Project <a href="https://grants.nih.gov/grants/funding/r01.htm">Grant</a> (R01) is the most common grant mechanism <a href="https://grants.nih.gov/grants/funding/r01.htm">distributed by the National Institutes for Health (NIH)</a>. The R01 supports health-related research and development that aligns with the principles of the NIH. Here is some useful information every researcher or future researcher can familiarize themselves about how these important funding mechanisms work.<p>Principle investigators may initiate an R01 application, meaning there are no specific guidelines, or potential grant recipients may be solicited through a Request for Application (RFA). In cases involving an RFA, an approximate amount of funds and number of awards to be made are established, as well as whether funds will be shared. Applicants submitting in response to an RFA normally have their submissions reviewed by a Scientific Review Group. In the event that unsolicited investigators apply for an R01, their research plan must correspond to at least one of the NIH Institutes and Centers&rsquo; missions.</p><p>R01 grants may be applied to the following costs, per NIH:</p><ul>
<li>Salary and fringe benefits for principal investigator, key personnel, and other essential personnel</li>
<li>Equipment and supplies</li>
<li>Consultant costs</li>
<li>Alterations and renovations</li>
<li>Publications and miscellaneous costs</li>
<li>Contract services</li>
<li>Consortium costs</li>
<li>Facilities and administrative costs (indirect costs)</li>
<li>Travel expenses</li>
</ul><h2><strong>Ideal R01 Candidates</strong></h2><p>R01s are a good choice for investigators with preliminary data as well as new investigators. An R01 provides four or five years of support, allowing investigators enough time not only to conduct their research but prepare applications for future awards in a timely manner. Newer investigators may benefit in particular for a number of reasons, according to NIH:</p><ul>
<li>New investigators are held to looser standards than more seasoned applicants (they may provide fewer preliminary data, resources, and publications)</li>
<li>New investigators are offered a more liberal payline for R01 applications</li>
<li>If the R01 application is rejected, it stands a better chance at garnering an R56-Bridge award or selective pay</li>
</ul><p>NIH notes that while application standards may be more laid back for new investigators, &ldquo;you still need to propose an important problem and use a sound research approach.&rdquo;</p><h2><strong>Important Dates</strong></h2><p>Deadlines for new grant applications are Feb. 5, June 5, and Oct. 5; renewal, resubmission, and revision grant applications must be submitted by March 5, July 5, and Nov. 5; and AIDS and AIDS-related grant applications are due on May 7, Sept. 7, and Jan. 7.</p><p>Sources: NIH-NIAID, NIH</p></p>


Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

What You Need To Know About R01 Grants

Career News

The Research Project Grant (R01) is the most common grant mechanism distributed by the National Institutes for Health (NIH). The R01 supports health-related research 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe